Merck Fails To Force Trial Of Bellwether Fosamax Case

Law360, New York (December 11, 2008, 12:00 AM EST) -- One of the bellwether plaintiffs in the multidistrict litigation over Merck & Co. Inc.'s osteoporosis drug Fosamax, who tried to drop her claims after Merck obtained a damaging deposition from one of her doctors, has finally gotten a judge's go-ahead to exit the MDL.

On Tuesday, Judge John F. Keenan of the U.S. District Court for the Southern District of New York granted a motion by Karen Denise Greene, one of three plaintiffs chosen for an early bellwether trial, to dismiss her own case.

Plaintiffs in...
To view the full article, register now.